ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease

Blood

Volumn 86, Issue 5, 1995, Pages 1694-1700

  Herbst, Hermann ^a,b   Anagnostopoulos, Joannis ^a   Heinze, Barbara ^a   Dürkop, Horst ^a   Hummel, Michael ^a   Stein, Harald ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; GENE PRODUCT; PROTEIN TYROSINE KINASE;

ARTICLE; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 5; CONTROLLED STUDY; GENE FUSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029165249     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.5.1694.bloodjournal8651694     Document Type: Article

References (31)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K. The expression of Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:849, 1985
2. Stein H, Dallenbach F: Diffuse large cell lymphomas of B- and T-cell type, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 675
3. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelényi G, Sundstrom C, Lennert K, van Unnik JAM, Mioduszewska O, Wright DH: Updated Kiel classification for malignant lymphomas. Lancet 1:292, 1988
4. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
5. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Rowe M, Young LS, Müller-Lantzsch N, Stein H: Epstein-Barr virus DNA and latent gene products in CD30-positive anaplastic large cell lymphomas. Blood 78:2666, 1991
6. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW: The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866, 1989
7. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Sakurai M, Tanaka H, Sasaki M, Suchi T, Kikuta A, Wakasa H, Hojo H, Mizutani S: A novel translocation. t(2;5)(p23;q35) in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
8. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW: Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305, 1990
9. Rimokh R, Magaud JP, Berger F, Samarut J, Coffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 71:31, 1989
10. Mason DY, Bastard C, Rimokh R, Dastague N, Huret JL, Kristofferson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet J, Warnke R: CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
11. Cabanillas F, Pathak S, Trujillo J, Grant G, Cork A, Hagemeister FB, Velasquez WS, Maclaughlin P, Redman J, Katz R, Butler JJ, Freireich EJ: Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte. Blood 71:1615, 1988
12. Schouten HC, Singer WG, Duggan M, Weisenburger DD, MacLennan KA, Armitage JO: Chromosomal abnormalities in Hodgkin's disease. Blood 73:2149, 1989
13. Tilly H, Bastard C, Delastre T, Duval C, Bizet M, Lenormand B, Daucé JP, Moncondiut M, Piguet H: Cytogenetic studies in untreated Hodgkin's disease. Blood 77:1298, 1991
14. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro D, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
15. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S: Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9:1567, 1994
16. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
17. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
18. Ladanyi M, Cavalchire G, Morris SW, Downing J, Filippa DA: Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol 145:1296, 1995
19. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC: Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? Lancet 345:87, 1995
20. + lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. Am J Pathol 146:328, 1995
21. Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Heintz F, Sueno K: Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep 66:615, 1982
22. Jones DB, Furley AJW, Gerdes J, Greaves MF, Stein H, Wright DH: Phenotypic and genotypic analyses of two cell lines derived from Hodgkin's disease tissue biopsies. Recent Results Cancer Res 117:62, 1988
23. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Hatanaka M, Honjo T: Cytochemical, immunologic, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 68:285, 1986
24. Fischer P, Nacheva E, Mason DY, Sherrington D, Hoyle C, Hayhoe FGJ, Karpas A: A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor β-chain gene. Blood 72:234, 1988
25. Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME: Constitutive secretion of soluble IL-2 receptor by a human T-cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble IL-2R in body fluids of the host mice. Am J Pathol 144:1089, 1994
26. Gogusev J, Barbey S, Nezelof C: Genotype markers and proto-oncogene analysis in the CD30-positive "malignant histiocytosis" DEL cell line with t(5;6)(q35;p21). Int J Cancer 46:106, 1990
27. Hecht BK, Epstein AL, Berger CS, Kaplan HS, Hecht F: Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies. Cancer Genet Cytogenet 14:205, 1985
28. de Breuil RM, Patel JM, Mendelow BV: Quantitation of β-actin-specific mRNA transcripts using xeno-competitive PCR. PCR Methods Appl 3:57, 1993
29. Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Müller-Lantzsch N, Stein H: Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 80:484, 1992
30. Ladanyi M, Parsa NZ, Offit K, Wachtel S, Jhanwar SC: Clonal cytogenetic abnormalities in Hodgkin's disease. Genes Chromosom Cancer 3:294, 1991
31. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith A, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045, 1994